NO20064822L - Progesteron reseptor modulatorer - Google Patents

Progesteron reseptor modulatorer

Info

Publication number: NO20064822L
Authority: NO; Norway
Prior art keywords: alkyl; optionally substituted; halogen; substituted; cyclopropenyl
Prior art date: 2004-03-25

Application number

NO20064822A

Other languages

English (en)

Norwegian (no)

Inventor

Johannes Bernardus Ma Rewinkel

Johannes Antonius Mar Hamersma

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-25

Filing date

2006-10-24

Publication date

2006-10-24

2006-10-24 Application filed by Organon Nv filed Critical Organon Nv

2006-10-24 Publication of NO20064822L publication Critical patent/NO20064822L/no

Links

239000002379 progesterone receptor modulator Substances 0.000 title 1
229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 10
229910052736 halogen Inorganic materials 0.000 abstract 5
150000002367 halogens Chemical class 0.000 abstract 5
125000003118 aryl group Chemical group 0.000 abstract 2
125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 abstract 2
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 2
125000004011 3 membered carbocyclic group Chemical group 0.000 abstract 1
125000001845 4 membered carbocyclic group Chemical group 0.000 abstract 1
125000001054 5 membered carbocyclic group Chemical group 0.000 abstract 1
125000004008 6 membered carbocyclic group Chemical group 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000005605 benzo group Chemical group 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20064822A 2004-03-25 2006-10-24 Progesteron reseptor modulatorer NO20064822L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US55621004P	2004-03-25	2004-03-25
EP04101241		2004-03-25
PCT/EP2005/051265 WO2005092912A1 (en)	2004-03-25	2005-03-18	Progesterone receptor modulators

Publications (1)

Publication Number	Publication Date
NO20064822L true NO20064822L (no)	2006-10-24

Family

ID=34928929

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064822A NO20064822L (no)	2004-03-25	2006-10-24	Progesteron reseptor modulatorer

Country Status (29)

Country	Link
US (1)	US7691836B2 (es)
EP (1)	EP1735330B1 (es)
JP (1)	JP4922918B2 (es)
KR (1)	KR20070028355A (es)
CN (1)	CN100549023C (es)
AR (1)	AR048330A1 (es)
AU (1)	AU2005225560B2 (es)
BR (1)	BRPI0509153A (es)
CA (1)	CA2560694C (es)
CY (1)	CY1107132T1 (es)
DE (1)	DE602005003564T2 (es)
DK (1)	DK1735330T3 (es)
EC (1)	ECSP066881A (es)
ES (1)	ES2297699T3 (es)
IL (1)	IL178010A0 (es)
LV (1)	LV13527B (es)
MX (1)	MXPA06010906A (es)
MY (1)	MY143074A (es)
NO (1)	NO20064822L (es)
NZ (1)	NZ549862A (es)
PE (1)	PE20060094A1 (es)
PL (1)	PL1735330T3 (es)
PT (1)	PT1735330E (es)
RU (1)	RU2381232C2 (es)
SI (1)	SI1735330T1 (es)
TW (1)	TW200531977A (es)
UA (1)	UA88782C2 (es)
WO (1)	WO2005092912A1 (es)
ZA (1)	ZA200607801B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016090139A1 (en) *	2014-12-03	2016-06-09	Evestra, Inc.	Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE290198C (es)
GB8513723D0 (en)	1985-05-31	1985-07-03	Erba Farmitalia	11-beta substituted steroids
IE60780B1 (en)	1987-01-23	1994-08-10	Akzo Nv	New 11-aryl steroid derivatives
EP0289073B1 (en)	1987-04-24	1991-11-27	Akzo N.V.	Novel 11-aryloestrane and 11-arylpregnane derivatives
EP0303306B1 (en)	1987-08-08	1993-03-10	Akzo N.V.	Contraceptive implant
DE3822770A1 (de) *	1988-07-01	1990-01-04	Schering Ag	13-alkyl-11ss-phenylgonane
DD290198A5 (de) *	1989-09-18	1991-05-23	Zi Fuer Mikrobiologie Und Experimentelle Therapie Jena,De	Verfahren zur herstellung von 11 beta-arylsubstituierten estra-4,9-dien-3-on-17(s)-spiro-1'-cyclohexan-2'-onen und 11 beta-arylsubstituierten estra-4,9-dien-3-on-17(s)-spiro-1'-cyclohexan-2'-olen sowie deren derivate
FR2658516B1 (fr)	1990-02-22	1992-06-12	Roussel Uclaf	Nouveaux produits sterouides comportant un radical spiro en position 17, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ZA929315B (en)	1991-12-20	1993-05-24	Akzo Nv	17-spirofuran-3'-ylidene steroids.
CA2100514C (en)	1992-07-29	2005-03-29	Johannes A. M. Hamersma	17-spiromethylene steroids
US5696130A (en)	1994-12-22	1997-12-09	Ligand Pharmaceuticals Incorporated	Tricyclic steroid receptor modulator compounds and methods
NZ332894A (en)	1996-06-25	1999-05-28	Akzo Nobel Nv	A regimen containing progestogen and/or estrogen with two or more anti-progestogen dosage units
IL123813A0 (en)	1997-04-11	1998-10-30	Akzo Nobel Nv	Drug delivery system for two or more active substances
TR200001334T2 (tr)	1997-11-14	2000-09-21	Akzo Nobel N.V.	Progestojen-anti-progestojen rejimleri.
US6020328A (en) *	1998-03-06	2000-02-01	Research Triangle Institute	20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6172052B1 (en) *	1998-12-04	2001-01-09	Research Triangle Institute	17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties

2005
- 2005-03-15 TW TW094107888A patent/TW200531977A/zh unknown
- 2005-03-18 US US10/594,103 patent/US7691836B2/en active Active
- 2005-03-18 RU RU2006137578/04A patent/RU2381232C2/ru not_active IP Right Cessation
- 2005-03-18 DE DE602005003564T patent/DE602005003564T2/de not_active Expired - Lifetime
- 2005-03-18 SI SI200530144T patent/SI1735330T1/sl unknown
- 2005-03-18 CA CA2560694A patent/CA2560694C/en not_active Expired - Fee Related
- 2005-03-18 MX MXPA06010906A patent/MXPA06010906A/es active IP Right Grant
- 2005-03-18 NZ NZ549862A patent/NZ549862A/en unknown
- 2005-03-18 CN CNB2005800096126A patent/CN100549023C/zh not_active Expired - Fee Related
- 2005-03-18 DK DK05733590T patent/DK1735330T3/da active
- 2005-03-18 EP EP05733590A patent/EP1735330B1/en not_active Expired - Lifetime
- 2005-03-18 JP JP2007504406A patent/JP4922918B2/ja not_active Expired - Fee Related
- 2005-03-18 BR BRPI0509153-5A patent/BRPI0509153A/pt not_active IP Right Cessation
- 2005-03-18 WO PCT/EP2005/051265 patent/WO2005092912A1/en not_active Ceased
- 2005-03-18 ES ES05733590T patent/ES2297699T3/es not_active Expired - Lifetime
- 2005-03-18 PT PT05733590T patent/PT1735330E/pt unknown
- 2005-03-18 PL PL05733590T patent/PL1735330T3/pl unknown
- 2005-03-18 KR KR1020067021801A patent/KR20070028355A/ko not_active Ceased
- 2005-03-18 UA UAA200609904A patent/UA88782C2/ru unknown
- 2005-03-18 AU AU2005225560A patent/AU2005225560B2/en not_active Ceased
- 2005-03-22 PE PE2005000328A patent/PE20060094A1/es not_active Application Discontinuation
- 2005-03-23 AR ARP050101145A patent/AR048330A1/es unknown
- 2005-03-24 MY MYPI20051276A patent/MY143074A/en unknown
2006
- 2006-09-11 IL IL178010A patent/IL178010A0/en unknown
- 2006-09-18 ZA ZA200607801A patent/ZA200607801B/en unknown
- 2006-09-25 EC EC2006006881A patent/ECSP066881A/es unknown
- 2006-10-24 NO NO20064822A patent/NO20064822L/no not_active Application Discontinuation
- 2006-10-24 LV LVP-06-120A patent/LV13527B/lv unknown
2008
- 2008-01-10 CY CY20081100031T patent/CY1107132T1/el unknown

Also Published As

Publication number	Publication date
BRPI0509153A (pt)	2007-11-20
UA88782C2 (en)	2009-11-25
US7691836B2 (en)	2010-04-06
CY1107132T1 (el)	2012-10-24
RU2381232C2 (ru)	2010-02-10
DK1735330T3 (da)	2008-03-31
SI1735330T1 (sl)	2008-04-30
DE602005003564T2 (de)	2008-10-23
TW200531977A (en)	2005-10-01
EP1735330A1 (en)	2006-12-27
EP1735330B1 (en)	2007-11-28
IL178010A0 (en)	2006-12-31
KR20070028355A (ko)	2007-03-12
ES2297699T3 (es)	2008-05-01
DE602005003564D1 (de)	2008-01-10
MY143074A (en)	2011-02-28
CN100549023C (zh)	2009-10-14
AR048330A1 (es)	2006-04-19
ECSP066881A (es)	2006-11-24
ZA200607801B (en)	2008-07-30
PE20060094A1 (es)	2006-02-24
JP4922918B2 (ja)	2012-04-25
HK1096405A1 (en)	2007-06-01
AU2005225560B2 (en)	2011-01-27
RU2006137578A (ru)	2008-04-27
CA2560694A1 (en)	2005-10-06
CA2560694C (en)	2012-03-06
AU2005225560A1 (en)	2005-10-06
NZ549862A (en)	2010-01-29
JP2007530501A (ja)	2007-11-01
LV13527B (en)	2007-04-20
PL1735330T3 (pl)	2008-05-30
MXPA06010906A (es)	2007-03-08
WO2005092912A1 (en)	2005-10-06
PT1735330E (pt)	2007-12-21
CN1934125A (zh)	2007-03-21
US20070203105A1 (en)	2007-08-30

Legal Events

Date	Code	Title	Description
2012-10-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
JP2008500997A5 (es)	2008-07-10
CY1105957T1 (el)	2011-04-06	Χρηση οιστρογονων ενωσεων σε συνδυασμο με ενωσεις προγεστογονου (progestogen) σε θepαπεια ορμονικης αντικαταστασης
BRPI0409938A (pt)	2006-04-25	derivados de azetidinacarboxamida e seu uso em terapia
AR044403A1 (es)	2005-09-14	Derivados de oximas y su uso como inmunodepresores. composiciones farmaceuticas que los contienen.
NO20070484L (no)	2007-03-26	Sammenspleisede pyrimidinderivater og sammensetninger derav som CXCR3 reseptormodulatorer, anvendbare ved forebygging og behandling av inflammatoriske og immunregulatoriske lidelser og sykdommer.
MX2021013075A (es)	2021-11-17	Oxisteroles y metodos de uso de los mismos.
JP2016536363A5 (es)	2018-11-29
BRPI0608732A2 (pt)	2016-11-08	composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
NO20064008L (no)	2006-09-06	Forbindelser
BR9714510A (pt)	2000-11-28	Processo e preparo de esteróides de 9,11-époxi e intermediários úteis dos mesmos
NO20054856D0 (no)	2005-10-20	4-anilo-kinazolinderivater som antiproliferative midler
EA201101089A1 (ru)	2012-02-28	Производные оксадиазола в качестве агонистов рецептора s1p1
TW200600086A (en)	2006-01-01	Chemical compound
BR0112856A (pt)	2003-07-01	Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos
AR068115A1 (es)	2009-11-04	Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
EP4321519A3 (en)	2024-05-01	Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders
PE20060590A1 (es)	2006-07-14	COMPUESTOS ESTEROIDALES 15ß-SUSTITUIDOS CON ACTIVIDAD SELECTIVA DEL RECEPTOR DE ESTROGENOS
JP2010523591A5 (es)	2012-05-24
AR053131A1 (es)	2007-04-25	Tetraciclinas 9-sustituidas
MX2010012303A (es)	2011-03-30	Agonista de receptor de glucocorticoide compuesto de derivado de 2,2,4-trimetil-6-fenil-1,2-dihidroquinolina que tiene un grupo oxi sustituido.
NO20064822L (no)	2006-10-24	Progesteron reseptor modulatorer
HUP0102867A2 (hu)	2002-05-29	Eljárás morfolinszármazékok előállítására
BR0211670A (pt)	2004-07-13	Processos para a produção de compostos e compostos
BRPI0511394A (pt)	2007-12-04	d-homo-estra-1,3,5(10)-trienos 2-substituìdos como inibidores de 17-hidróxi esteróide desidrogenase tipo 1
JP2011524352A5 (es)	2014-01-30